Financial calendar
Year-end report Q4 2023: 26 January 2024
Annual Report 2023: 15 April 2024
Q1 Report 2024: 29 April 2024
Annual General Meeting: 29 May 2024
Interim Report Q2 2024: 30 August 2024
Interim Report Q3 2024: 29 October 2024
Year-end Report Q4 2024: 29 January 2025
Upcoming events
10 December 2024, Swedish Ministry for Foreign Affairs roundtable on “Leveraging Technology and Innovation to Ensure Every Child is Vaccinated", Stockholm
29 - 30 January 2025, mRNA-Based Therapeutics Summit Europe, Frankfurt
Annual general meetings
Annual General Meeting 2024
Ziccum AB held its Annual General Meeting of shareholders on Wednesday May 29, 2024.
Time: 15.00
Place: Scheelevägen 22, Lund
Bulletin from the Annual General Meeting (in English) here:
Ziccum - Kommuniké ÅS24 ENG (FSEN 240524)
Kommuniké från årsstämma i Ziccum AB (publ) (på svenska) här:
Ziccum - Kommuniké ÅS24 (FSEN 240524)
Minutes / Protokoll from the AGM (in Swedish and English)
Ziccum - Komplettering till kallelse ÅS24
Ziccum - Kallelse ÅS24 (FSEN 240422)
Ziccum - Fullmaktsformulär ÅS24
Ziccum - Fullmaktsformulär ÅS24 ENG
Styrelsens förslag till ny bolagsordning ÅS24
Ziccum - Styrelsens förslag till ny bolagsordning ÅS24 (1)
Valberedningens förslag till beslut om incitamentsprogram 2024.
Ziccum - Valberedningens förslag till beslut om incitamentsprogram 2024.1 (2)
LTI 2024.1 - Bilaga A1 Avtal om kvalificerade personaloptioner
Ziccum - LTI 2024.1 - Bilaga A1 Avtal om kvalificerade personaloptioner (2)
LTI 2024.1 - Bilaga A2 Optionsvillkor
Ziccum - LTI 2024.1 - Bilaga A2 Optionsvillkor (1)
Styrelsens förslag till beslut om incitamentsprogram 2024.2
Ziccum - Styrelsens förslag till beslut om incitamentsprogram 2024.2 (1)
LTI 2024.2 - Bilaga A Optionsvillkor
Ziccum - LTI 2024.2 - Bilaga A Optionsvillkor (1)
General Meeting
The General Meeting is the highest decision-making body of a public limited company. The Meeting appoints the Board of Directors and auditors, and also decides on matters such as amendments to the Articles of Association and changes in share capital. Under the Companies Act, Swedish public limited companies must hold a general meeting at which the Board submits the annual report and the audit report within six months of the end of each year. This shareholder meeting is called the Annual General Meeting (AGM).
Election of Board of Directors/Nomination Committee
The composition of the Board of Directors is determined by vote at the AGM, in compliance with the Swedish Companies Act and Ziccums’ articles of association.
Nomination Committee
The main task of the Nomination Committee is to propose candidates to the AGM for election to the Board.
The Nomination Committee also formulates proposals for chairman of the AGM, remuneration to the Board of Directors, remuneration to the auditors, and principles for appointments to the Nomination Committee. The Nomination Committee's mandate applies to the 2024 Annual General Meeting. Nomination Committee members receive no remuneration from the Company other than compensation for direct costs incurred. The Nomination Committee for the AGM 2024 consists of the following persons:
- William Lithander
- Göran Conradson
- Kenneth Hopp
Annual General Meeting 2023
Ziccum's 2023 Annual General Meeting was held on Tuesday May 24, 2023
Documents:
Rights Issue Q1 2024
DISCLAIMER: The information on this part of Ziccum’s website is not intended for, and may not, directly or indirectly, in whole or in part, be accessed by, or distributed or disseminated to, persons residing or located in the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require a prospectus, registration or other measures other than those required by Swedish law. The information on the website does not constitute an offer of unit rights, paid subscribed units, units, shares or warrants issued by Ziccum (”Securities”) to any person in such jurisdictions. Nor may the information on the web pages be forwarded or reproduced in a way that contravenes such restrictions or would entail such requirements.
No Securities have been registered or will be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state or other jurisdiction in the United States and may not be offered, subscribed for, exercised, pledged, sold, resold, assigned, delivered or otherwise transferred, directly or indirectly, in or into the United States, except in accordance with any exemptions accepted by Ziccum.
Ziccum reserves the right to accept subscriptions under any exemption from a person who is in or registered in a jurisdiction where participation would otherwise require a prospectus, registration or other measures than those required by Swedish law.
Within the European Economic Area (”EEA”), no offer to the public of Securities is made in any country other than Sweden. In other member states of the European Union (”EU”), such an offer can only be made in accordance with exemptions in the Prospectus Regulation (EU) 2017/1129 (the ”Prospectus Regulation”).
On 22 January 2024 Ziccum announced that it was carrying out a Directed New Share Issue and Rights Issue as part of a combined financial package to secure working capital for continued business and technical development. In this section you will find the relevant forms, information and materials needed to take part in the new Issue.
Den 22 januari 2024 meddelade Ziccum att de kommer genomföra en riktad nyemission och företrädesemission som en del av ett kombinerat finansiellt paket för att säkerställa rörelsekapital för fortsatt bolagsutveckling. Här hittar du relevanta formulär, information och material som behövs för att ta del av denna företrädesemission.
Information Memorandum (English)
Ziccum_Report2024_ENG_K_Final_HighRes
Press release (English)
ziccum-secures-financing-into-2025-through-a-combined-directed-share-issue-and-rights-issue-to-finance-the-continued-execution-of-its-ambitious-business-plan
Pressmeddelandet (Swedish)
ziccum-sakrar-finansiering-till-2025-genom-kombinerad-riktad-emission-och-foretradesemission-for-fortsatt-genomforande-av-den-ambitiosa-affarsplanen
Särskild anmälningssedel för teckning av units med företrädesrätt
Särskild anmälningssedel
Anmälningssedel för teckning av units utan företräde i Ziccum AB
Anmälningssedel för teckning utan företräde
Subscription of units without subscription rights in Ziccum AB
Subscription form for subscription without preferential rights
Villkor för teckningsoptioner av serie TO 5 (Swedish and English document)
Fullständiga villkor TO5 (AQU 240119) (1)
Registreringsbevis från Bolagsverket (Swedish)
Certificate of Registration, Q4 2024
e-Certificate of Registration, Swedish Companies Registration Office (English)
Certificate of Registration, Q1 2024
Board's Statement Chapter 14, Section 32 of the Swedish Companies Act
Auditor's Statement Chapter 14, Section 32 of the Swedish Companies Act
Rights Issue Q4 2024
DISCLAIMER: The information on this part of Ziccum’s website is not intended for, and may not, directly or indirectly, in whole or in part, be accessed by, or distributed or disseminated to, persons residing or located in the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require a prospectus, registration or other measures other than those required by Swedish law. The information on the website does not constitute an offer of unit rights, paid subscribed units, units, shares or warrants issued by Ziccum (”Securities”) to any person in such jurisdictions. Nor may the information on the web pages be forwarded or reproduced in a way that contravenes such restrictions or would entail such requirements.
No Securities have been registered or will be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state or other jurisdiction in the United States and may not be offered, subscribed for, exercised, pledged, sold, resold, assigned, delivered or otherwise transferred, directly or indirectly, in or into the United States, except in accordance with any exemptions accepted by Ziccum.
Ziccum reserves the right to accept subscriptions under any exemption from a person who is in or registered in a jurisdiction where participation would otherwise require a prospectus, registration or other measures than those required by Swedish law.
Within the European Economic Area (”EEA”), no offer to the public of Securities is made in any country other than Sweden. In other member states of the European Union (”EU”), such an offer can only be made in accordance with exemptions in the Prospectus Regulation (EU) 2017/1129 (the ”Prospectus Regulation”).
The Board of Directors of Ziccum AB (publ) (“Ziccum” or the “Company”) announces today its intention to carry out a new issue of shares and warrants (“Units”) with pre-emption rights for the Company’s shareholders (the”Rights Issue”). The Board of Directors intends to publish a notice to an extraordinary general meeting planned to be held on 8 November 2024, to grant the Board of Directors an authorization to resolve on the Rights Issue and for the adoption of new articles of association. Each Unit consists of one (1) share and one (1) warrant free of charge of series TO 6 (“Warrants”). Upon full subscription in the Rights issue, the Company will initially receive approximately SEK 30 million in issue proceeds before issue costs. In connection with the Rights Issue, the Company has received subscription and guarantee undertakings amounting up to a total of approximately SEK 11.6 million, corresponding up to approximately 39 percent of the Rights Issue. The issue proceeds will primarily be used to further the technological development of LaminarPace®. To secure the Company’s liquidity needs until the completion of the Rights Issue, the Company has secured a SEK 6.5 million bridge loan from VIFC Nordic AB and Dariush Hosseinian.
Styrelsen för Ziccum AB (publ) ("Ziccum" eller "Bolaget") offentliggör idag sin avsikt att genomföra en nyemission av aktier och teckningsoptioner ("Units") med företrädesrätt för Bolagets aktieägare ("Företrädesemissionen"). Styrelsen avser att offentliggöra en kallelse till en extra bolagsstämma planerad att hållas den 8 november 2024, för att ge styrelsen bemyndigande att besluta om Företrädesemissionen och för antagande av en ny bolagsordning. Varje Unit består av en (1) aktie och en (1) vederlagsfri teckningsoption av serie TO 6 ("Teckningsoptionerna"). Vid full teckning i Företrädesemissionen kommer Bolaget initialt att tillföras cirka 30 miljoner kronor i emissionslikvid före emissionskostnader. I samband med Företrädesemissionen har Bolaget erhållit tecknings- och garantiåtaganden uppgående till totalt cirka 11,6 miljoner kronor, motsvarande upp till cirka 39 procent av Företrädesemissionen. Emissionslikviden kommer i första hand att användas för att fortsätta den tekniska utvecklingen av LaminarPace®. För att säkerställa Bolagets likviditetsbehov fram till dess att Företrädesemissionen slutförts har Bolaget säkrat brygglån om 6,5 miljoner kronor från VIFC Nordic AB och Dariush Hosseinian.
Rights Issue Q4 2024, Certificate of Registration
Rights Issue Q4 2024, Articles of Association Amendment Proposal
Rights Issue Q4 2024, EGM Notice in English
Rights Issue Q4 2024, EGM Notice in Swedish
Rights Issue Q4 2024, Proxy Form
Rights Issue Q4 2024, TO6 Terms and Conditions
Rights Issue Q4 2024, Prospectus
Rights Issue Q4 2024, Teckning med företrädesrätt
Corporate governance
Ziccum AB is a Swedish public limited company governed by Swedish legislation, mainly the Swedish Companies Act (2005: 551) and the Swedish Annual Accounts Act (1995: 1554).
Following the listing of the Company’s shares on Nasdaq First North, the Company will apply and adhere to Nasdaq First North’s rules and regulations.
Ziccum’s auditor is PwC, MALMÖ.
The Auditor in Charge is Anders Ola Bjärehäll,
Box 4009,
203 11 MALMÖ
Ziccum's Articles of Association (in Swedish)
Owners
| Name | Number of Shares | Percentage of Ownership |
| Global Corporate Finance (GCF) | 1,153,831 | 7.24% |
| Avanza Pension | 1,045,156 | 6.56% |
| William Lithander | 940,000 | 5.90% |
| Göran Conradson | 760,738 | 4.77% |
| Tigerstaden AS | 421,189 | 2.64% |
| Nordnet Pensionsförsäkring | 363,515 | 2.28% |
| Kenneth Hopp | 276,050 | 1.73% |
| Per Gerde | 244,444 | 1.53% |
| Other Shareholders | 10,730,348 | 67.34% |
| Total | 15,934,895 | 100% |
Certified advisor
The company’s Certified Adviser is
Vator Securities AB
Telefon: +46 8 5800 6599
E-mail: ca@vatorsec.se